Galectins in cancer: carcinogenesis, diagnosis and therapy
A major breakthrough in the field of medical oncology has been the discovery of galectins and their role in cancer development, progression and metastasis. In this review article we have condensed the results of a number of studies published over the past decade in an effort to shed some light on th...
Saved in:
Published in | Annals of translational medicine Vol. 2; no. 9; p. 88 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
China
AME Publishing Company
01.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A major breakthrough in the field of medical oncology has been the discovery of galectins and their role in cancer development, progression and metastasis. In this review article we have condensed the results of a number of studies published over the past decade in an effort to shed some light on the unique role played by the galectin family of proteins in neoplasia, and how this knowledge may alter the approach to cancer diagnosis as well as therapy in the future. In this review we have also emphasized the potential use of galectin inhibitors or modulators in the treatment of cancer and how this novel treatment modality may affect patient outcomes in the future. Based on current pre-clinical models we believe the use of galectin inhibitors/modulators will play a significant role in cancer treatment in the future. Early clinical studies are underway to evaluate the utility of these promising agents in cancer patients. |
---|---|
AbstractList | A major breakthrough in the field of medical oncology has been the discovery of galectins and their role in cancer development, progression and metastasis. In this review article we have condensed the results of a number of studies published over the past decade in an effort to shed some light on the unique role played by the galectin family of proteins in neoplasia, and how this knowledge may alter the approach to cancer diagnosis as well as therapy in the future. In this review we have also emphasized the potential use of galectin inhibitors or modulators in the treatment of cancer and how this novel treatment modality may affect patient outcomes in the future. Based on current pre-clinical models we believe the use of galectin inhibitors/modulators will play a significant role in cancer treatment in the future. Early clinical studies are underway to evaluate the utility of these promising agents in cancer patients. |
Author | Rakhshanda, Rahman Jenkins, Marjorie Grizzi, Fabio Ebrahim, Ali Hasan Nguyen, Diane Cobos, Everardo Dahlbeck, Scott Figueroa, Jose A Alalawi, Zainab Chiriva-Internati, Maurizio Mirandola, Leonardo |
Author_xml | – sequence: 1 givenname: Ali Hasan surname: Ebrahim fullname: Ebrahim, Ali Hasan organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 2 givenname: Zainab surname: Alalawi fullname: Alalawi, Zainab organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 3 givenname: Leonardo surname: Mirandola fullname: Mirandola, Leonardo organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 4 givenname: Rahman surname: Rakhshanda fullname: Rakhshanda, Rahman organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 5 givenname: Scott surname: Dahlbeck fullname: Dahlbeck, Scott organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 6 givenname: Diane surname: Nguyen fullname: Nguyen, Diane organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 7 givenname: Marjorie surname: Jenkins fullname: Jenkins, Marjorie organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 8 givenname: Fabio surname: Grizzi fullname: Grizzi, Fabio organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 9 givenname: Everardo surname: Cobos fullname: Cobos, Everardo organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 10 givenname: Jose A surname: Figueroa fullname: Figueroa, Jose A organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy – sequence: 11 givenname: Maurizio surname: Chiriva-Internati fullname: Chiriva-Internati, Maurizio organization: 1 Department of Surgery, 2 Internal Medicine Department, Salmaniya Medical Complex, Kingdom of Bahrain ; 3 Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA ; 4 Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA ; 5 Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA ; 6 Kiromic, LLC, TX, USA ; 7 Humanitas Clinical and Research Center, Milan, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25405163$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkE9LAzEQxYMottZ-BVnw4sGuk2T_JD0IUrQKBS96XmazkzZlm62brdBv74K11NN7vBl-D94VO_eNJ8ZuOcRS5-phHbsQfCwkpJNUSR0L4EkMOubijA2P8fmJH7BxCGsA4IJrCXDJBiJNIOWZHLLpHGsynfMhcj4y6A21015b43yzJE_Bhfuocrj0TW8j9FXUrajF7f6aXVisA40POmKfL88fs9fJ4n3-NntaTIwUSTdRRoCxlmwCyJUqK425MRlUucpLBUhCc5Rk0VpMhZCp1FharbTOywyVlSP2-Mvd7soNVYZ812JdbFu3wXZfNOiK_xfvVsWy-S4SAanKVA-4OwDa5mtHoSs2Lhiqa_TU7ELBM5HxLElA9K83p13Hkr_B5A-mC3Qn |
CitedBy_id | crossref_primary_10_1007_s11696_021_02026_7 crossref_primary_10_3389_fgene_2023_1122864 crossref_primary_10_1021_acs_biomac_9b01370 crossref_primary_10_1186_s13046_021_02095_2 crossref_primary_10_1186_s13048_021_00874_1 crossref_primary_10_3390_ijms22116000 crossref_primary_10_1007_s11248_021_00276_5 crossref_primary_10_3389_fcvm_2023_1052959 crossref_primary_10_3389_fonc_2021_706862 crossref_primary_10_3390_ijms23126414 crossref_primary_10_3390_cancers13194819 crossref_primary_10_5483_BMBRep_2020_53_4_020 crossref_primary_10_18786_2072_0505_2024_52_006 crossref_primary_10_3389_fimmu_2024_1352454 crossref_primary_10_3389_fonc_2021_809170 crossref_primary_10_3390_molecules25215121 crossref_primary_10_4132_jptm_2015_02_25 crossref_primary_10_3390_jcm10153313 crossref_primary_10_3389_fendo_2023_1124111 |
ContentType | Journal Article |
Copyright | 2014 Annals of Translational Medicine. All rights reserved. 2014 Annals of Translational Medicine. |
Copyright_xml | – notice: 2014 Annals of Translational Medicine. All rights reserved. 2014 Annals of Translational Medicine. |
DBID | NPM 7X8 5PM |
DOI | 10.3978/j.issn.2305-5839.2014.09.12 |
DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2305-5839 |
EndPage | 88 |
ExternalDocumentID | 25405163 |
Genre | Journal Article Review |
GroupedDBID | 53G ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL DIK HYE M~E NPM OK1 RPM 7X8 5PM |
ID | FETCH-LOGICAL-c324t-8c20cffef40a188bd9a7cc60d787b80ae291a3efaffa5223539abf98997b6a8f3 |
IEDL.DBID | RPM |
ISSN | 2305-5839 |
IngestDate | Fri Sep 01 02:35:41 EDT 2023 Thu Apr 11 15:46:10 EDT 2024 Thu May 23 23:19:54 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 9 |
Keywords | galectins solid tumors lectins Cancer |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c324t-8c20cffef40a188bd9a7cc60d787b80ae291a3efaffa5223539abf98997b6a8f3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 These authors contributed equally for the first authorship. These authors contributed equally for the senior authorship. |
PMID | 25405163 |
PQID | 1626164402 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4205868 proquest_miscellaneous_1626164402 pubmed_primary_25405163 |
PublicationCentury | 2000 |
PublicationDate | 2014-Sep 20140901 |
PublicationDateYYYYMMDD | 2014-09-01 |
PublicationDate_xml | – month: 09 year: 2014 text: 2014-Sep |
PublicationDecade | 2010 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Annals of translational medicine |
PublicationTitleAlternate | Ann Transl Med |
PublicationYear | 2014 |
Publisher | AME Publishing Company |
Publisher_xml | – name: AME Publishing Company |
References | 21958686 - J Exp Clin Cancer Res. 2011 Sep 29;30:89 24939371 - Glycobiology. 2014 Oct;24(10):899-906 18264727 - J Cancer Res Clin Oncol. 2008 Aug;134(8):899-907 20382700 - Am J Pathol. 2010 Jun;176(6):3023-31 19286570 - Am J Pathol. 2009 Apr;174(4):1515-23 24560493 - Lung Cancer. 2014 Apr;84(1):73-8 23389289 - Carcinogenesis. 2013 Jun;34(6):1370-81 24281352 - Mol Biosyst. 2014 Feb;10(2):258-65 18319555 - J Med Invest. 2008 Feb;55(1-2):127-32 21949569 - World J Biol Chem. 2011 Sep 26;2(9):193-201 23179497 - J Neurooncol. 2013 Jan;111(2):123-32 12727847 - Cancer Res. 2003 May 1;63(9):2251-5 20363921 - Am J Pathol. 2010 May;176(5):2067-81 22986745 - Cancer Res. 2012 Nov 15;72(22):5757-66 23985992 - Oncotarget. 2013 Sep;4(9):1461-71 23929302 - Int J Cancer. 2014 Feb 15;134(4):873-84 23824659 - PLoS One. 2013 Jun 18;8(6):e65957 22237208 - Cell Death Dis. 2012 Jan 12;3:e251 22622427 - J Invest Dermatol. 2012 Sep;132(9):2245-54 22696230 - Clin Cancer Res. 2012 Aug 1;18(15):4037-47 15487449 - Am J Clin Pathol. 2004 Oct;122(4):524-31 23917726 - Cancer Biol Ther. 2013 Oct 1;14(10):897-906 22900040 - PLoS One. 2012;7(8):e42699 24139517 - Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):975-82 20592339 - Anticancer Res. 2010 May;30(5):1547-52 20162566 - Int J Cancer. 2010 Dec 1;127(11):2530-41 25189484 - Clin Cancer Res. 2014 Nov 1;20(21):5558-69 22939954 - Hum Pathol. 2013 Jan;44(1):62-8 15837748 - Clin Cancer Res. 2005 Apr 15;11(8):2962-8 18313712 - Toxicol Appl Pharmacol. 2008 Jun 1;229(2):172-83 24511119 - J Am Soc Nephrol. 2014 Jul;25(7):1486-95 22892876 - World J Urol. 2013 Apr;31(2):351-8 8063692 - J Biol Chem. 1994 Aug 19;269(33):20807-10 20546628 - BMC Cancer. 2010 Jun 15;10:290 23643871 - Gynecol Oncol. 2013 Dec;131(3):645-9 21933892 - Clin Cancer Res. 2011 Nov 15;17(22):7035-46 24339976 - PLoS One. 2013 Dec 10;8(12):e81883 19818782 - Gastroenterology. 2010 Mar;138(3):1035-45.e1-2 23204230 - Cancer Res. 2013 Feb 1;73(3):1107-17 22513979 - J Pathol. 2012 Sep;228(1):56-66 21350102 - Am J Clin Pathol. 2011 Mar;135(3):454-60 16112008 - Hum Pathol. 2005 Aug;36(8):908-14 20299755 - J Med Invest. 2010 Feb;57(1-2):152-7 9988230 - Int J Cancer. 1999 Feb 19;84(1):39-43 23967302 - PLoS One. 2013 Aug 14;8(8):e72468 22291012 - J Biol Chem. 2012 Mar 23;287(13):9753-64 23015305 - J Gastroenterol. 2013 Mar;48(3):350-9 |
References_xml | |
SSID | ssj0001219300 |
Score | 2.277951 |
SecondaryResourceType | review_article |
Snippet | A major breakthrough in the field of medical oncology has been the discovery of galectins and their role in cancer development, progression and metastasis. In... |
SourceID | pubmedcentral proquest pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 88 |
SubjectTerms | Highlighted Reports in Galectins |
Title | Galectins in cancer: carcinogenesis, diagnosis and therapy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25405163 https://search.proquest.com/docview/1626164402 https://pubmed.ncbi.nlm.nih.gov/PMC4205868 |
Volume | 2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT8IwGG2Qg_FiNP7CX5nRo4N13daWmyEiMcF4kITb0natzkghDA7-937dGAG9edkOXZPl-9ruve59rwjdRcZIKbH2oyxM4EJiX2JpfK61JlRmiQ5cvfPwJRmMoudxPG6guK6FKUX7SuZt-zVp2_yj1FbOJqpT68Q6r8NeFAYxS1hnB-1QQjYoerWxApikLD0BdB27qiK-i24dOwXC1Pks51Z73eTEXaXTKXbn2oQOv2BnCfoXbv5WTW58hvoHaH-FH72H6j0PUUPbI9R9Em73PbeFl1tPuUTOu3Cfq9xO391qlhf3Xlap6vLCEzbzqsKr72M06j--9Qb-6lAEXwH2WfhMhYEyRpsoEJgxmXFBlUqCDGaeZIHQIceCaCOMEYCtSEy4kIYDraIyEcyQE9S0U6vPkEdZBgAIqwwgYMSDWNDIuYFxbIyh1IgWuqmjkMKgc38ShNXTZZFioEHAs4B7ttBpFZV0VrljpHUMW4huxWv9gDO03m6BPJfG1qu8nv-75wXac_msNGCXqLmYL_UVgIaFvC4HyQ-vysH_ |
link.rule.ids | 230,315,733,786,790,891,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV25TsQwEB1xSEDDIa7lDIKSHM7lhA4hYDkWUbCILrIdGwKsF-1RwNczTjYIlgqapHBSeDxO3rPfPAMchEpxzom0w9yP8RJENidc2amUMqA8j6Vn6p1bN3GzHV4-RA8TENW1MKVoX_DC0a8dRxdPpbbyrSPcWifm3rZOQt-LkjhxJ2Ea56tPv5H0amkFUUlZfIL4OjJ1RekM7Bt-ipTJfS5nl_PVZORdpdcpMSfb-AbBEGMK-htwjusmv_2Izhbgvu5CpT95cYYD7oiPMXfHP_dxEeZH0NQ6rpqXYELqZTg6Z2Zhv9B9q9CWMDnSO8J7TxS6-2g-lEX_0MorwV7Rt5jOraqm630F2mendydNe3Tegi0QVg3sRPieUEqq0GMkSXieMipE7OU4qXniMemnhAVSMaUYwrYgClLGVYqMjfKYJSpYhSnd1XIdLJrkiK2IyBFdhqkXMRoao7GUKKUoVawBe3V4M8xns0nBtOwO-xlBhoUUDmltA9aqcGdvlfFGVg9OA-iPgfh6wHhl_2zB8Jae2aNwbvz7zV2Ybd61rrPri5urTZgzSVNJzbZgatAbym3EJgO-U2biJyHy4_g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV25TsQwEB1xSIiGQ1zLGQQlOZzbdAhYbkQBEqKJfEKA9a72KODrGSe7aIGOJinsFB6Pk_ecN88A-7HWnHOi3FiGKV6ixOWEa5cqpaKMy1QFtt755jY9f4gvH5PHsaO-KtG-4KVn3lueKV8qbWWnJfyRTsy_uzmOwyDJ09zvSO1PwjSu2ZCOEfV6ewWRSVWAghg7sbVFdAb2LEdF2uS_VivM-26yEq_K75TY021Ci2KINQb9Czp_ayfHPkbNeXgaDaPWoLx5gz73xOcvh8d_jXMB5oYQ1TmquyzChDJLcHjG7AZ_aXpOaRxhc6V7iPeuKE372b4wy96BI2vhXtlzmJFOXdv1sQwPzdP743N3eO6CKxBe9d1chIHQWuk4YCTPuaQsEyINJC5ungdMhZSwSGmmNUP4FiURZVxTZG4ZT1muoxWYMm2j1sDJcokYiwiJKDOmQcKy2BqOUaK1zjLNGrA7CnGBeW1_VjCj2oNeQZBpIZVDetuA1TrkRac24ChGE9SA7MdkfHewntk_WzDElXf2MKTr_35yB2buTprF9cXt1QbM2rypFWebMNXvDtQWQpQ-366S8QtaVOZ4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Galectins+in+cancer%3A+carcinogenesis%2C+diagnosis+and+therapy&rft.jtitle=Annals+of+translational+medicine&rft.au=Ebrahim%2C+Ali+Hasan&rft.au=Alalawi%2C+Zainab&rft.au=Mirandola%2C+Leonardo&rft.au=Rakhshanda%2C+Rahman&rft.date=2014-09-01&rft.pub=AME+Publishing+Company&rft.issn=2305-5839&rft.eissn=2305-5839&rft.volume=2&rft.issue=9&rft_id=info:doi/10.3978%2Fj.issn.2305-5839.2014.09.12&rft_id=info%3Apmid%2F25405163&rft.externalDBID=PMC4205868 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2305-5839&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2305-5839&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2305-5839&client=summon |